![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 12
Zeitschriftenartikel
Moretti, A.; Fonteyne, L.; Giesert, F.; Hoppmann, P.; Meier, A. B.; Bozoglu, T.; Baehr, A.; Schneider, C. M.; Sinnecker, D.; Klett, K.; Fröhlich, T.; Rahman, F. Abdel; Haufe, T.; Sun, S.; Jurisch, V.; Kessler, B.; Hinkel, R.; Dirschinger, R.; Martens, E.; Jilek, C.; Graf, A.; Krebs, S.; Santamaria, G.; Kurome, M.; Zakhartchenko, V.; Campbell, B.; Voelse, K.; Wolf, A.; Ziegler, T.; Reichert, S.; Lee, S.; Flenkenthaler, F.; Dorn, T.; Jeremias, I.; Blum, H.; Dendorfer, A.; Schnieke, A.; Krause, S.; Walter, M. C.; Klymiuk, N.; Laugwitz, K. L.; Wolf, E.; Wurst, W. und Kupatt, C.
(2020):
Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.
In: Nature Medicine, Bd. 26, Nr. 2: S. 207-214
[PDF, 5MB]
Reiter, K.; Polzer, H.; Krupka, C.; Maiser, A.; Vick, B.; Rothenberg-Thurley, M.; Metzeler, K. H.; Doerfel, D.; Salih, H. R.; Jung, G.; Noessner, E.; Jeremias, I.; Hiddemann, W.; Leonhardt, H.; Spiekermann, K.; Subklewe, M. und Greif, P. A.
(2018):
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia.
In: Leukemia, Bd. 32, Nr. 2: S. 313-322
Valtierra-Gutierrez, I. A.; Farre-Orteu, A.; Richter, M.; Greif, P. A.; Ziegenhain, C.; Jeremias, I.; Metzeler, K.; Spiekermann, K.; Enard, W. und Hellmann, I.
(2017):
Detection of Single-Nucleotide Variants in Acute Myeloid Leukemia (AML) from Bulk and Single-Cell RNA Sequencing.
In: Annals of Hematology, Bd. 96:
S57-S57
Heckl, B. C.; Carlet, M.; Grunert, M.; Vick, B.; Roolf, C.; Junghanss, C.; Spiekermann, K.; Hiddemann, W. und Jeremias, I.
(2017):
Adult primary acute leukemia samples with chromosomal translocations grow well in immunodeficient mice, but are difficult to transduce with lentiviruses.
In: Haematologica, Bd. 102: S. 656-657
Ebinger, S.; Liu, W.; Tiedt, Sebastian; Alves, Catarina Castro und Jeremias, I.
(2017):
A Rare Population of Drug Resistant, Dormant Stem Cells Exists in Patients' Acute Lymphoblastic Leukemia Growing in Mice.
In: Annals of Hematology, Bd. 96:
S52-S52
Heckl, B.; Carlet, M.; Grunert, M.; Vick, B.; Roolf, C.; Junghanss, C.; Spiekermann, K.; Hiddemann, W. und Jeremias, I.
(2017):
Primary Adult Acute Lymphoblastic Leukemic Cells Reliably Engraft and Grow in Immunodeficient Mice.
In: Annals of Hematology, Bd. 96:
S71-S72
Oezdemir, E.; Ziegenhain, C.; Panzer-Grünmayer, R.; Enard, W. und Jeremias, I.
(2017):
A Preclinical PDX Model for Patients` Minimal Residual Disease in ALL.
In: Annals of Hematology, Bd. 96:
S74-S74
Vick, B.; Holdt, L. M.; Hiddemann, W.; Spiekermann, K. und Jeremias, I.
(2017):
Modeling AML Standard Induction Chemotherapy in the PDX Mouse Model.
In: Annals of Hematology, Bd. 96:
S68-S68
Koczian, F.; Vomacka, J.; Vick, B.; Hettich, B.; Kazmaier, U.; Sieber, S.; Jeremias, I.; Vollmar, A. und Braig, S.
(2017):
Targeting the ER-Mitochondrial Interface of Cell Death Sensitizes Leukemia Cells towards Cytostatics.
In: Annals of Hematology, Bd. 96:
S73-S73
Vergalli, J.; Carlet, M.; Hoffmann, T.; Roth, M.; Zuber, J. und Jeremias, I.
(2017):
XIAP is an Attractive Therapeutic Target for all as Validated in Innovative Genetically Engineered Patient-Derived Xenograft Models.
In: Annals of Hematology, Bd. 96:
S74-S75
Bagnoli, Johannes; Ziegenhain, C.; Vieth, B.; Parekh, S.; Vick, B.; Jeremias, I.; Hellmann, I. und Enard, W.
(2017):
Transcriptional Heterogeneity in AML - Evolution of Gene Expression in Patient Derived Xenografts.
In: Annals of Hematology, Bd. 96:
S59-S59
Krupka, C.; Kufer, P.; Kischel, R.; Zugmaier, G.; Lichtenegger, F. S.; Köhnke, T.; Vick, B.; Jeremias, I.; Metzeler, K. H.; Altmann, T.; Schneider, S.; Fiegl, M.; Spiekermann, K.; Bauerle, P. A.; Hiddemann, W.; Riethmüller, G. und Subklewe, M.
(2016):
Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism.
In: Leukemia, Bd. 30, Nr. 2: S. 484-491